Radio-immunoassay method for determining bupropion and active metabolites thereof and a test kit for use in the assay method
CA 1188984 A · Owner: Wellcome Foundation Limited (The) · Inventors: Butz, Robert F.; Findlay, John W.A.; Welch, Richard M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
An assay method of determining the concentration of bupropion and any active metalbolites thereof in a body fluid comprises (a) mixing together antisera comprising bupropion -specific antibodies, a labelled competitor of bupropion capable of competing with bupripion for binding to said antisera and body fluid, (b) mixing together a concentration of a standard amount of bupropion antisera and, labelled competitor, and (c) measuring the portion of labelled competitor either bound or unbound to the antibodies in each of step (a) and step (b) and comparing the results for step (a) with the results for step (b); the method is useful in determining the presence of bupropion a pharmacologically, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted June 18, 1985. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended June 18, 2002.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.